- Home
- NBY vs AYRO Comparison
NBY vs AYRO Comparison
Compare NBY & AYRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBY
- AYRO
- Stock Information
- Founded
- NBY 2000
- AYRO 2017
- Country
- NBY United States
- AYRO United States
- Employees
- NBY N/A
- AYRO N/A
- Industry
- NBY
- AYRO Telecommunications Equipment
- Sector
- NBY
- AYRO Consumer Discretionary
- Exchange
- NBY Nasdaq
- AYRO Nasdaq
- Market Cap
- NBY 3.8M
- AYRO 3.7M
- IPO Year
- NBY 2007
- AYRO N/A
- Fundamental
- Price
- NBY $0.91
- AYRO $7.08
- Analyst Decision
- NBY Strong Buy
- AYRO
- Analyst Count
- NBY 1
- AYRO 0
- Target Price
- NBY $0.85
- AYRO N/A
- AVG Volume (30 Days)
- NBY 9.7M
- AYRO 77.1K
- Earning Date
- NBY 08-14-2025
- AYRO 08-14-2025
- Dividend Yield
- NBY N/A
- AYRO N/A
- EPS Growth
- NBY N/A
- AYRO N/A
- EPS
- NBY 0.41
- AYRO N/A
- Revenue
- NBY $9,781,000.00
- AYRO $5,426.00
- Revenue This Year
- NBY $23.91
- AYRO N/A
- Revenue Next Year
- NBY $32.05
- AYRO N/A
- P/E Ratio
- NBY $2.69
- AYRO N/A
- Revenue Growth
- NBY 113.47
- AYRO N/A
- 52 Week Low
- NBY $0.44
- AYRO $5.17
- 52 Week High
- NBY $1.25
- AYRO $15.28
- Technical
- Relative Strength Index (RSI)
- NBY 66.42
- AYRO 54.00
- Support Level
- NBY $0.88
- AYRO $5.73
- Resistance Level
- NBY $1.25
- AYRO $7.03
- Average True Range (ATR)
- NBY 0.08
- AYRO 0.67
- MACD
- NBY 0.04
- AYRO -0.01
- Stochastic Oscillator
- NBY 52.14
- AYRO 61.14
About NBY NovaBay Pharmaceuticals Inc.
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.
About AYRO AYRO Inc.
AYRO Inc designs and manufactures compact, sustainable electric vehicles for closed campus mobility, low-speed urban and community transport, local on-demand and last-mile delivery, and government use. It operates as one reportable segment, focusing on the manufacturing and sales of environmentally-conscious, minimal-footprint EVs.